1. Home
  2. ARE vs STVN Comparison

ARE vs STVN Comparison

Compare ARE & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alexandria Real Estate Equities Inc.

ARE

Alexandria Real Estate Equities Inc.

HOLD

Current Price

$47.14

Market Cap

8.8B

Sector

Real Estate

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$21.43

Market Cap

7.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARE
STVN
Founded
1994
1949
Country
United States
Italy
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Containers/Packaging
Sector
Real Estate
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
7.4B
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
ARE
STVN
Price
$47.14
$21.43
Analyst Decision
Hold
Buy
Analyst Count
10
4
Target Price
$69.38
$25.38
AVG Volume (30 Days)
3.1M
338.7K
Earning Date
01-26-2026
11-06-2025
Dividend Yield
10.03%
0.30%
EPS Growth
N/A
19.61
EPS
N/A
0.60
Revenue
$3,058,395,000.00
$1,373,219,524.00
Revenue This Year
N/A
$8.42
Revenue Next Year
N/A
$9.52
P/E Ratio
N/A
$34.83
Revenue Growth
N/A
6.97
52 Week Low
$44.10
$17.81
52 Week High
$105.14
$28.00

Technical Indicators

Market Signals
Indicator
ARE
STVN
Relative Strength Index (RSI) 35.11 39.50
Support Level $44.10 $20.50
Resistance Level $47.19 $22.29
Average True Range (ATR) 1.68 1.09
MACD 0.40 -0.08
Stochastic Oscillator 28.91 12.23

Price Performance

Historical Comparison
ARE
STVN

About ARE Alexandria Real Estate Equities Inc.

Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

Share on Social Networks: